150 related articles for article (PubMed ID: 15023417)
1. Plasma cell differentiation and multiple myeloma.
Shapiro-Shelef M; Calame K
Curr Opin Immunol; 2004 Apr; 16(2):226-34. PubMed ID: 15023417
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown.
Lin FR; Kuo HK; Ying HY; Yang FH; Lin KI
Cancer Res; 2007 Dec; 67(24):11914-23. PubMed ID: 18089822
[TBL] [Abstract][Full Text] [Related]
3. Key differentiation steps in normal B cells and in myeloma cells.
Zubler RH
Semin Hematol; 1997 Jan; 34(1 Suppl 1):13-22. PubMed ID: 9122741
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the B-cell receptor signaling component CD79b in plasma cell myeloma: a possible post transcriptional regulation.
Huang X; Takata K; Sato Y; Tanaka T; Ichimura K; Tamura M; Oka T; Yoshino T
Pathol Int; 2011 Mar; 61(3):122-9. PubMed ID: 21355953
[TBL] [Abstract][Full Text] [Related]
5. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
6. CD38 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation.
Manjarrez-Orduño N; Moreno-García ME; Fink K; Santos-Argumedo L
Eur J Immunol; 2007 Feb; 37(2):358-67. PubMed ID: 17274001
[TBL] [Abstract][Full Text] [Related]
7. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression.
Kallies A; Hasbold J; Tarlinton DM; Dietrich W; Corcoran LM; Hodgkin PD; Nutt SL
J Exp Med; 2004 Oct; 200(8):967-77. PubMed ID: 15492122
[TBL] [Abstract][Full Text] [Related]
9. Initiation of antigen receptor-dependent differentiation into plasma cells by calmodulin inhibition of E2A.
Hauser J; Verma-Gaur J; Wallenius A; Grundström T
J Immunol; 2009 Jul; 183(2):1179-87. PubMed ID: 19553523
[TBL] [Abstract][Full Text] [Related]
10. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
[TBL] [Abstract][Full Text] [Related]
11. Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias.
Decourt C; Galea HR; Sirac C; Cogné M
J Leukoc Biol; 2004 Sep; 76(3):528-36. PubMed ID: 15155772
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells.
Silvestris F; Cafforio P; De Matteo M; Calvani N; Frassanito MA; Dammacco F
Clin Cancer Res; 2008 Oct; 14(19):6081-91. PubMed ID: 18829486
[TBL] [Abstract][Full Text] [Related]
13. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
14. Terminal differentiation of lymphocytes depends on Blimp-1.
Kallies A; Nutt SL
Curr Opin Immunol; 2007 Apr; 19(2):156-62. PubMed ID: 17291741
[TBL] [Abstract][Full Text] [Related]
15. Use of differentiating adult stem cells (marrow stromal cells) to identify new downstream target genes for transcription factors.
Ylöstalo J; Smith JR; Pochampally RR; Matz R; Sekiya I; Larson BL; Vuoristo JT; Prockop DJ
Stem Cells; 2006 Mar; 24(3):642-52. PubMed ID: 16439615
[TBL] [Abstract][Full Text] [Related]
16. Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation.
Igarashi K; Ochiai K; Muto A
J Biochem; 2007 Jun; 141(6):783-9. PubMed ID: 17569706
[TBL] [Abstract][Full Text] [Related]
17. CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract][Full Text] [Related]
18. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program.
Shaffer AL; Lin KI; Kuo TC; Yu X; Hurt EM; Rosenwald A; Giltnane JM; Yang L; Zhao H; Calame K; Staudt LM
Immunity; 2002 Jul; 17(1):51-62. PubMed ID: 12150891
[TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanisms that determine the development and function of plasma cells.
Calame KL; Lin KI; Tunyaplin C
Annu Rev Immunol; 2003; 21():205-30. PubMed ID: 12524387
[TBL] [Abstract][Full Text] [Related]
20. POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17.
Zhao C; Inoue J; Imoto I; Otsuki T; Iida S; Ueda R; Inazawa J
Oncogene; 2008 Jan; 27(1):63-75. PubMed ID: 17621271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
